Nu-Med Plus, Inc.
NUMD
$0.06
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.30K | 17.40K | 16.00K | 20.60K | 55.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.30K | 17.40K | 16.00K | 20.60K | 55.30K |
| Operating Income | -9.30K | -17.40K | -16.00K | -20.60K | -55.30K |
| Income Before Tax | -10.60K | -18.70K | -17.30K | -21.80K | -56.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.60K | -18.70K | -17.30K | -21.80K | -56.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.60K | -18.70K | -17.30K | -21.80K | -56.60K |
| EBIT | -9.30K | -17.40K | -16.00K | -20.60K | -55.30K |
| EBITDA | -- | -- | -- | -- | -54.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 90.15M | 81.35M | 81.35M | 83.55M | 82.65M |
| Average Diluted Shares Outstanding | 90.15M | 81.35M | 81.35M | 83.55M | 82.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |